T(CD3+)-, B(CD19+)-lymphocytes and their subsets (CD4+, CD8+, CD3+, DR+, CD3− DR+) in peripheral blood of patients with CIN I, CIN II, CIN III and cancerin situ associated with HPV infection were evaluated. In peripheral blood of women with CIN II, CIN III and cancerin situ the number of T-lymphocytes which expressed CD3+ DR+ antigen decreased. In patients with CIN I, CIN III and cancerin situ the level of the CD4+ cells decreased; the level of the CD8+ cells increased. These patients had a lower CD4/CD8 ratio, the number of B cells being standard. The results may have important implications in the prognosis and immunotherapy of HPV infection.
Cervical Cancer Human Leukocyte Antigen Mixed Infection Cervical Intraepithelial Neoplasia Lymphocyte Subpopulation
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.
Bartholomew J.S., Stacey S.N., Coles B.: Identification of a naturally processed HLA A0201-restricted viral peptide from cell expressing human papillomavirus type 16 E6 oncoprotein.Eur. J. Immunol.24, 3175–3179 (1994).PubMedCrossRefGoogle Scholar
Bosch F.E., Manoz M.M., Munoz N.: Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.J. Nat. Cancer Inst.87, 796–802 (1995).PubMedCrossRefGoogle Scholar
Boyum A.: Separation of leukocytes from blood and bone marrow.Scand. J. Clin. Lab. Invest.21, 28–33 (1968).Google Scholar
Chardonnet Y., Bejuithivolet F., Viac J.: Squamous epithelia and human papillomavirus infections.Pathol. Biol.40, 247–256 (1992).PubMedGoogle Scholar
Clerici M., Stocks N.I., Zajac R.A.: Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients.J. Clin. Invest.84, 1892–1899 (1989).PubMedCrossRefGoogle Scholar
Clerici M., Merola M., Ferrario E.: Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection limited to the cervix or involving other sites of the lower genital tract.J. Nat. Cancer Inst.89, 245–250 (1997).PubMedCrossRefGoogle Scholar
Flander A.N., Adams M., Evans A.S.: Immunocompetent for immunotherapy—a study of the immunocompetence of cervical-cancer patients.Internat. J. Gynecol. Cancer5, 438–442 (1995).CrossRefGoogle Scholar
Koutsky L.A., Holmes K.K., Critchlow C.W., Stevens C.E., Paavonen J., Beckmann A.M.: A control study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection.New Engl. J. Med.327, 1272–1278 (1992).PubMedCrossRefGoogle Scholar
Lakatosh V.P., Lazarenko L.N., Spivak N.Ya., Lyanenko L.A.: Immune response under HPV-infection and diseases of female genital organs associated with it.Likars'ka Sprava (Kiev)7, 25–36 (1998).Google Scholar
Lakatosh V.P.: Cryosurgical treatment of the benign processes of the cervix uteri associated with papillomavirus infection.Bull. Vinnytsia State Med. Univ.1, 96–97 (1999).Google Scholar
Lakatosh V.P., Lazarenko L.N., Lyanenko L.A., Dubchak V.E.: Present ideas on papillomavirus infection and its part in pathogenesis of pretumour and tumour processes in cervix uteri.Likars'ka Sprava (Kiev)2, 22–32 (1999).Google Scholar
Meisels A., Ruiz P.:HPV and Cervical Cancer, pp. 67–85 (1989).Google Scholar
Pinegin B.V., Minkina G.N., Korshunova O.V., Saprikin B.V., Saprikina O.A., Kulakov A.V., Bossart V., Karsonova M.I.: State of the local and system immunity in patients with papillomavirus cervical infection as affected by immunomodulator solkotrichovak.Immunologiya4, 45–48 (1997).Google Scholar
Rast W.M., Feltkamp M.C.W., Ressing M.E.: Cellular immunity against human papillomavirus-associated cervical cancer.Semin. Virol.7, 117–123 (1986).Google Scholar
Reid A., Stanhope C.R., Huschman B.R.: Colposcopia.Amer. J. Obstet. Gynecol.149, 815–823 (1984).Google Scholar
Soutter W.P., Kesic V.: Treatment of cervical intraepithelial neoplasia reverses CD4CD8 lymphocyte abnormalities in peripheral venous-blood.Internat. J. Gynecol. Cancer4, 279–282 (1994).CrossRefGoogle Scholar
Stern P.L.: Immunity to human papillomavirus-associated cervical neoplasia.Adv. Cancer Res.69, 175–211 (1996).PubMedGoogle Scholar
Wu T.-C., Kurman R.J.: Analysis of cytokine profiles in patient with human papillomavirus associated neoplasms.J. Nat. Cancer Inst.89, 185–187 (1997).PubMedCrossRefGoogle Scholar